The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. A variety of strategies are employed enhance antibody titer, including process parameter optimization, cell line development, and implementation of perfusion systems. Fine-tuning growth paramete